Endothelial dysfunction in Chronic Obstructive Pulmonary Disease patients according to exposure by tobacco or biomass

R. Davila Ramos (ciudad de México , Mexico), Y. Pilotzi Montiel (ciudad de México , Mexico), D. Gonzales Islas (ciudad de México , Mexico), A. Orea Tejeda (ciudad de México , Mexico), M. Salgado Fernández (ciudad de México , Mexico), A. Jimenez Valentín (ciudad de México , Mexico), A. Flores Vargas (ciudad de México , Mexico), R. Sánchez Santillán (ciudad de México , Mexico), R. Martínez Memije (ciudad de México , Mexico), S. Cid Juárez (ciudad de México , Mexico), O. Infante Vazquez (ciudad de México , Mexico)

Source: International Congress 2019 – Asthma and COPD comorbidities
Session: Asthma and COPD comorbidities
Session type: Oral Presentation
Number: 3291
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Davila Ramos (ciudad de México , Mexico), Y. Pilotzi Montiel (ciudad de México , Mexico), D. Gonzales Islas (ciudad de México , Mexico), A. Orea Tejeda (ciudad de México , Mexico), M. Salgado Fernández (ciudad de México , Mexico), A. Jimenez Valentín (ciudad de México , Mexico), A. Flores Vargas (ciudad de México , Mexico), R. Sánchez Santillán (ciudad de México , Mexico), R. Martínez Memije (ciudad de México , Mexico), S. Cid Juárez (ciudad de México , Mexico), O. Infante Vazquez (ciudad de México , Mexico). Endothelial dysfunction in Chronic Obstructive Pulmonary Disease patients according to exposure by tobacco or biomass. 3291

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Chronic Obstructive Pulmonary Disease Due to Biomass Smoke or Tobacco as risk factor to cachexia.
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019

Chronic Obstructive Pulmonary Disease (COPD)
Source: Eur Respir Rev 2009; 18: 133
Year: 2009


Sexuality in Chronic Obstructive Pulmonary Disease (SEXY COPD)
Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases
Year: 2020

“Asthma-like features” in Chronic Obstructive Pulmonary Disease (COPD) patients
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018

Chronic Obstructive Pulmonary Disease Exacerbations
Source: Eur Respir Rev 2009; 18: 305
Year: 2009


Effectiveness of pulmonary rehabilitation initiated after exacerbation of Chronic Obstructive Pulmonary Disease
Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care
Year: 2018

Effects of a self-management program in exacerbated Chronic Obstructive Pulmonary Disease
Source: International Congress 2019 – Airway infection in COPD
Year: 2019

Impact of abnormal body water distribution on prognostic of Chronic Obstructive Pulmonary Disease and heart failure patients.
Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases
Year: 2020

Level of control of Chronic Obstructive Pulmonary Disease according to clinical phenotypes. Study SINCON
Source: International Congress 2017 – What is new in COPD diagnosis and classification?
Year: 2017


Effect of smoking on the specific cholinergic hypersensitivity of airways in patients with Chronic Obstructive Pulmonary Disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 178s
Year: 2002

Association of Metabolic Syndrome with the severity of Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2020 – Clinical data and COPD management
Year: 2020


Determinants of Airflow Limitation in Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair
Year: 2020

Pathogenic bacteria for exacerbation of Chronic Obstructive Pulmonary Disease
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018

Evaluation of Co-morbidities among Different Chronic Obstructive Pulmonary Disease Phenotypes
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018


Pharmacological treatment of stable Chronic Obstructive Pulmonary Disease: Where do we stand?
Source: International Congress 2018 – COPD management
Year: 2018


Distribution of body water in hospitalized patients with Chronic Obstructive Pulmonary Disease and Right Heart Failure.
Source: International Congress 2019 – Cardiovascular comorbidities in COPD
Year: 2019


Metabolic paralysis in systemic immune cells of Chronic Obstructive Pulmonary Disease (COPD) subjects.
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018


Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2020 - Pre-reading material
Year: 2020

Effect of roflumilast on cytokines levels in patients with Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Year: 2021


Dysfunctional breathing impacts symptom burden in Chronic Obstructive Pulmonary Disease (COPD).
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020